Beiersdorf is investing in the Düsseldorf-based start-up 'dermanostic' through its OSCAR&PAUL Venture Capital unit.
The young company is active in the field of digital health and offers app-based dermatological diagnosis.
The dermanostic service can be booked around the clock for €25, irrespective of location. Experienced dermatologists offer diagnoses within 24 hours after patients have uploaded three photos and filled out a medical history questionnaire.
In less serious cases, dermanostic can eliminate the need for a patient to visit a dermatological practice and can provide fast solutions for an individual skin problem, for example by sending the prescription by mail or digitally via online pharmacies.
Ascan Voswinckel, head of OSCAR&PAUL Beiersdorf Venture Capital, sees this latest investment and collaboration with dermanostic as an important step.
"We believe digital health and teledermatology offer huge potential, especially among the younger target group. Digital dermatologist appointments offer our consumers significant added value as they allow for swift, straightforward, inexpensive, and professional advice regarding their skin indication," he said and continued, "As such, dermanostic’s new digital service is the perfect fit for our Eucerin brand and innovatively complements our dermocosmetic brand’s digital consumer journey.”
Commenting on the acquisition, Cornelius Becker, Beiersdorf’s head of Derma, said, "The collaboration with dermanostic is a relevant aspect of our digitalisation strategy. Especially in these times of COVID-19 and physical distancing, we must find digital ways of offering our consumers the right advice to solve their skin problems.
"By engaging in close communication with the experts at dermanostic, we can learn from one another and thus do even better at establishing digital closeness with our consumers."
OSCAR&PAUL Beiersdorf Venture Capital Unit
True to the spirit of Beiersdorf’s founding fathers Oscar Troplowitz and Paul Beiersdorf, the OSCAR&PAUL Beiersdorf Venture Capital unit invests in innovative companies and start-ups.
The unit aims to generate mutual value and jointly expedite forward-looking technologies, new business models, and skincare innovations.
In addition to its investment in dermanostic, OSCAR&PAUL Beiersdorf Venture Capital invested, among others, in the personalised skincare brand Routinely in May 2021.
This brand focuses on a modular skincare routine, which takes the dynamic nature of skin into account on the basis of an online questionnaire and an app.